FIRST-LINE TREATMENT CHOICE FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: WHAT DO CLINICIANS CARE ABOUT? THE CLL FITNESS STUDY

被引：0
|
作者：
Scarfo, L. [1 ,2 ]
Quaresmini, G. [3 ,4 ]
Ambrosetti, A. [5 ]
Laurenti, L. [6 ]
Rossini, F. [7 ,8 ]
Trentin, L. [9 ]
Coscia, M. [10 ]
Orlandi, E. [11 ]
Mannina, D. [12 ]
Torreggiani, A. [13 ]
Rambaldi, A. [3 ,4 ]
Semenzato, G. [9 ]
Innocenti, I. [6 ]
Brugiatelli, M. [12 ]
Cuneo, A. [14 ]
Foa, R. [1 ,2 ,3 ,4 ]
Molica, S. [1 ,2 ,5 ]
Morra, E. [1 ,2 ,6 ]
Pane, F. [1 ,2 ,7 ,8 ]
Pizzolo, G. [5 ]
Ghia, P. [1 ,2 ]
机构：
[1] Ist Sci San Raffaele, Dept Oncohematol, Lymphoma Unit, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
[3] Azienda Osped Papa Giovanni XXIII, Hematol Unit, Bergamo, Italy
[4] Azienda Osped Papa Giovanni XXIII, Bone Marrow Transplant Unit, Bergamo, Italy
[5] Policlin GB Rossi, Dept Hematol, Verona, Italy
[6] Univ Cattolica Sacro Cuore, Inst Hematol, I-00168 Rome, Italy
[7] Osped San Gerardo, Div Ematol, Monza, Italy
[8] Osped San Gerardo, Ctr TMO, Monza, Italy
[9] Univ Padua, Sch Med, Dept Med, Hematol & Clin Immunol Branch, Padua, Italy
[10] Azienda Osped Univ Citta Salute & Sci Torino, Div Hematol, Turin, Italy
[11] Fdn IRCCS Policlin San Matteo, Dept Oncohematol, Hematol Unit, Pavia, Italy
[12] Osped Papardo, Div Ematol, Messina, Italy
[13] Fdn IRCCS Policlin San Matteo, Pavia, Italy
[14] Azienda Osped Univ S Anna, Sect Hematol, Ferrara, Italy
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1512
引用
收藏
页码：587 / 587
页数：1
相关论文
共 50 条
  • [41] Assessing Adoption of Standard of Care and Comparing Clinical and Demographic Differences in First-Line (1L) Treatment (Tx) of Chronic Lymphocytic Leukemia (CLL)
    Hou, Jing-Zhou
    Gart, Michael
    Vasudevan, Anupama
    Katzen, Harvey I.
    Choksi, Rushir
    Blanc, Simon
    BLOOD, 2023, 142
  • [42] First Line Treatment of Chronic Lymphocytic Leukemia (CLL) Patients With Obinutuzumab Based Therapy: Single-Center Experience
    Trajkova, Sanja
    Pivkova-Veljanovska, Aleksandra
    Krstevska-Balkanov, Svetlana
    Popova-Labacevska, Marija
    Ridova, Nevenka
    Stojanovska-Jakimovska, Simona
    Cvetanovski, Milche
    Chadievski, Lazar
    Kocoski, Bozidar
    Panovska-Stavridis, Irina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S326 - S326
  • [43] Lenalidomide as Initial Treatment of Elderly Patients with Chronic Lymphocytic Leukemia (CLL)
    Ferrajoli, Alessandra
    O'Brien, Susan
    Wierda, William
    Faderl, Stefan
    Kornblau, Steven
    Yerrow, Kimberly
    Estrov, Zeev
    Kantarjian, Hagop
    Keating, Michael
    BLOOD, 2008, 112 (11) : 23 - 23
  • [44] Fludarabine, Cyclophosphamide and Rituximab (FCR) As First Line Treatment in Patients with Chronic Lymphocytic Leukemia (CLL): A Long-Term Analysis of the German CLL Study Group (GCLLSG) Registry
    Kutsch, Nadine
    Fink, Anna Maria
    Federhen, Anno
    Giza, Adam
    Robrecht, Sandra
    Stumpf, Janina
    Stoltefuss, Andrea
    Vehling-Kaiser, Ursula
    Koenigsmann, Michael
    Tausch, Eugen
    Schneider, Christof
    Stilgenbauer, Stephan
    Illmer, Thomas
    Schlag, Rudolf
    Doerfel, Steffen
    Gaska, Tobias
    Kiehl, Michael G.
    Fischer, Kirsten
    Eichhorst, Barbara
    Hallek, Michael
    BLOOD, 2022, 140 : 9879 - 9881
  • [45] REAL-WORLD ECONOMIC OUTCOMES OF FIRST-LINE (1L) IBRUTINIB TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL)
    Challagulla, S.
    Lee, P.
    Kistler, K.
    Douyon, L.
    Lai, D.
    Iyengar, R.
    VALUE IN HEALTH, 2021, 24 : S38 - S38
  • [46] IMPACT OF TREATMENT AND PATIENT ATTRIBUTES ON ONCOLOGISTS DECISION-MAKING IN FIRST-LINE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN THE UNITED STATES (US)
    Sharma, D.
    Deering, K.
    Sundaram, M.
    Daly, K.
    Huang, Q.
    VALUE IN HEALTH, 2021, 24 : S50 - S50
  • [47] Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
    O. Al-Sawaf
    S. Robrecht
    J. Bahlo
    A. M. Fink
    P. Cramer
    J. v Tresckow
    E. Lange
    M. Kiehl
    M. Dreyling
    M. Ritgen
    J. Dürig
    E. Tausch
    C. Schneider
    S. Stilgenbauer
    C. M. Wendtner
    K. Fischer
    M. Goede
    B. Hallek
    Leukemia, 2021, 35 : 169 - 176
  • [48] Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
    Al-Sawaf, O.
    Robrecht, S.
    Bahlo, J.
    Fink, A. M.
    Cramer, P.
    Von Tresckow, J.
    Lange, E.
    Kiehl, M.
    Dreyling, M.
    Ritgen, M.
    Duerig, J.
    Tausch, E.
    Schneider, C.
    Stilgenbauer, S.
    Wendtner, C. M.
    Fischer, K.
    Goede, V
    Hallek, M.
    Eichhorst, B.
    LEUKEMIA, 2021, 35 (01) : 169 - 176
  • [49] A Retrospective Population-Based Study of a Series of 307 Treatment-naive Patients with Chronic Lymphocytic Leukemia (CLL): Study of the Clinical Features and Efficacy of First-Line Therapy
    Ma Donato, Eva
    Andreu, Rafa
    Lopez, Aurelio
    Vicente, Ana
    Carral, Ana
    Jarque, Isidro
    Angeles Ruiz, M.
    Carbonell, Felix
    Osma, Mar
    Blanes, Margarita
    Ferrer, Rosa
    Garcia, Alfonso
    Marin, Francisca
    Lorente, Pablo
    Dolores Garcia, Ma
    Fernanda Palmero, Ma
    Antonio Fernandez, Jose
    Montagud, Mario
    Blanquer, Miguel
    Jose Lis, Ma
    Irene Petruskevicius, Paula
    Tormo, Mar
    Jose Terol, Maria
    BLOOD, 2010, 116 (21) : 1018 - 1018
  • [50] Physical Fitness As A Determinant Of Leukemia Cell Biology In Treatment-Naive Chronic Lymphocytic Leukemia (CLL)
    Bartlett, David B.
    Sitlinger, Andrea
    Deal, Michael
    Connelly, Margery A.
    Stewart, Tiffany
    Guadalupe, Eross
    MacDonald, Grace
    Kraus, William E.
    Weinberg, J. Brice
    Brander, Danielle B.
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2020, 52 (07) : 986 - 986
12345